Coagulation in patients with severe sepsis

Area of Science:

• Biochemistry
• Immunology
• Pathophysiology

Background:

• Severe sepsis involves systemic coagulation activation.
• A complex interplay exists between coagulation and inflammation in sepsis pathogenesis.
• Inflammation activates coagulation and suppresses natural anticoagulant mechanisms.

Purpose of the Study:

• To elucidate the molecular pathways linking inflammation and coagulation activation in sepsis.
• To understand how coagulation affects inflammatory activity during sepsis.
• To explore therapeutic strategies targeting coagulation in sepsis.

Main Methods:

• Identification of molecular pathways involved in inflammation-induced coagulation.
• Analysis of cytokine effects on anticoagulant systems (Protein C, TFPI).
• Investigation of fibrinolysis inhibition by plasminogen activator inhibitor type 1 (PAI-1).

Main Results:

• Proinflammatory cytokines activate coagulation by upregulating tissue factor and downregulating TFPI.
• The protein C system is inhibited by proinflammatory cytokines.
• Fibrin removal is impaired due to PAI-1 upregulation, leading to microvascular thrombosis and organ damage.

Conclusions:

• The cross-talk between coagulation and inflammation is central to sepsis-induced organ damage.
• Inhibition of coagulation activation, such as with heparin, shows promise.
• Restoring physiological anticoagulant pathways is a potential therapeutic avenue.